Immediate Impact
4 from Science/Nature 61 standout
Citing Papers
Encorafenib, cetuximab and chemotherapy in BRAF-mutant colorectal cancer: a randomized phase 3 trial
2025 Standout
Multi drug resistance in Colorectal Cancer- approaches to overcome, advancements and future success
2024 Standout
Works of Setsuo Utsunomiya being referenced
BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancer
2011
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Setsuo Utsunomiya | 322 | 99 | 128 | 183 | 21 | 455 | |
| Manuel Chaves-Conde | 330 | 88 | 127 | 62 | 24 | 479 | |
| Santiago Aparo | 228 | 31 | 95 | 40 | 30 | 377 | |
| V. K. Vaitkevicius | 163 | 45 | 66 | 57 | 22 | 436 | |
| Xiaowei Dang | 217 | 93 | 162 | 36 | 32 | 487 | |
| Hong Pan | 179 | 45 | 80 | 66 | 27 | 447 | |
| Katia Dotti | 350 | 56 | 145 | 108 | 28 | 490 | |
| G D’Haens | 289 | 69 | 145 | 81 | 19 | 413 | |
| T.-Y. Kim | 203 | 120 | 120 | 74 | 19 | 391 | |
| Greenspan Em | 154 | 21 | 43 | 63 | 23 | 397 | |
| Supriya Patel | 200 | 59 | 69 | 122 | 15 | 414 |
All Works
Loading papers...